Industry Analysis & Industry Trends
In 2013, revenue for the Pharmaceutical Manufacturing industry is expected to total $94.4 billion, up 14.5% from 2012. This represents an annualized growth rate of 18.8% since 2008. The industry's profitability has also been increasing – from 10.3% of industry revenue in 2008 to 10.9% in 2013. There are about 1,417 industry enterprises in 2013, employing about 602,031 people with a payroll of about $5.8 billion.
Hospitals are currently the main distribution channel for medicines produced by this industry. However, upcoming healthcare reforms will enable drugstores to become the major distribution channel in the near future. In the past, many consumers could not afford to purchase medicine or see a doctor.... purchase to read more
Industry Report - Starting a New Business Chapter
Substantial barriers to entry to the industry exist as globalized players continue their development in China. The top 20 globalized pharmaceutical companies have established manufacturing companies in China as either joint ventures or solely foreign-owned enterprises. Some of these companies, such as GSK, Roche, Novo Nordisk, AstraZeneca and Eli Lilly & Company, have also set up R&D centers in China. Further, some domestic companies, particularly the major players within this industry, also have significant market strengths on a local basis.
China is a major manufacturing center for generic drugs. With numerous pharmaceuticals having long patent times, almost all of which are from foreign companies, this is a major barrier for new firms to enter the industry... purchase to read more